352 related articles for article (PubMed ID: 29587700)
1. Serum (1→3)-β-D-glucan and galactomannan levels in patients with cystic fibrosis: a retrospective cohort study.
Träger J; Melichar VO; Meyer R; Rauh M; Bogdan C; Held J
BMC Pulm Med; 2018 Mar; 18(1):52. PubMed ID: 29587700
[TBL] [Abstract][Full Text] [Related]
2. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K; Sands D
Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
[TBL] [Abstract][Full Text] [Related]
3. Novel immunologic classification of aspergillosis in adult cystic fibrosis.
Baxter CG; Dunn G; Jones AM; Webb K; Gore R; Richardson MD; Denning DW
J Allergy Clin Immunol; 2013 Sep; 132(3):560-566.e10. PubMed ID: 23726262
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Serum Galactomannan and 1,3-Beta-D-Glucan Determination for Early Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hematological Malignancies and Septic Shock.
Lahmer T; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W
Mycopathologia; 2016 Aug; 181(7-8):505-11. PubMed ID: 27142781
[TBL] [Abstract][Full Text] [Related]
6. Invasive pulmonary aspergillosis due to Aspergillus terreus: value of DNA, galactomannan and (1->3)-beta-D-glucan detection in serum samples as an adjunct to diagnosis.
Mokaddas E; Burhamah MHA; Ahmad S; Khan ZU
J Med Microbiol; 2010 Dec; 59(Pt 12):1519-1523. PubMed ID: 20724511
[TBL] [Abstract][Full Text] [Related]
7. Detection of Aspergillus fumigatus-specific DNA, (1-3)-beta-D-glucan and galactomannan in serum and bronchoalveolar lavage specimens of experimentally infected rats.
Khan ZU; Ahmad S; Theyyathel AM
Mycoses; 2008 Mar; 51(2):129-35. PubMed ID: 18254749
[TBL] [Abstract][Full Text] [Related]
8. Aspergillus Bronchitis in Patients with Cystic Fibrosis.
Brandt C; Roehmel J; Rickerts V; Melichar V; Niemann N; Schwarz C
Mycopathologia; 2018 Feb; 183(1):61-69. PubMed ID: 28819878
[TBL] [Abstract][Full Text] [Related]
9. Development of a novel inhalational model of invasive pulmonary aspergillosis in rats and comparative evaluation of three biomarkers for its diagnosis.
Ahmad S; Al-Shaikh AA; Khan Z
PLoS One; 2014; 9(6):e100524. PubMed ID: 24955575
[TBL] [Abstract][Full Text] [Related]
10. Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum.
Baxter CG; Rautemaa R; Jones AM; Webb AK; Bull M; Mahenthiralingam E; Denning DW
Thorax; 2013 Jul; 68(7):652-7. PubMed ID: 23513028
[TBL] [Abstract][Full Text] [Related]
11. The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-D-glucan in patients without risk factors for invasive fungal infections.
Metan G; Ağkuş C; Buldu H; Koç AN
Infection; 2010 Jun; 38(3):217-21. PubMed ID: 20237947
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of serum galactomannan, (1,3)-β-d-glucan, and Aspergillus fumigatus-specific IgA and IgG assays for invasive pulmonary aspergillosis in non-neutropenic patients.
Dobias R; Jaworska P; Tomaskova H; Kanova M; Lyskova P; Vrba Z; Holub C; Svobodová L; Hamal P; Raska M
Mycoses; 2018 Aug; 61(8):576-586. PubMed ID: 29575150
[TBL] [Abstract][Full Text] [Related]
13. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis.
Reece E; Segurado R; Jackson A; McClean S; Renwick J; Greally P
BMC Pulm Med; 2017 Apr; 17(1):70. PubMed ID: 28431569
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of
Takazono T; Ito Y; Tashiro M; Nishimura K; Saijo T; Yamamoto K; Imamura Y; Miyazaki T; Yanagihara K; Mukae H; Izumikawa K
J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30842231
[TBL] [Abstract][Full Text] [Related]
15. The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis.
Amin R; Dupuis A; Aaron SD; Ratjen F
Chest; 2010 Jan; 137(1):171-6. PubMed ID: 19567494
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of serum human Galactomannan aspergillus antigen and 1,3-beta-D-glucan in immunocompromised patient suspected fungal infection.
Susianti H; Parmadi L; Firani NK; Setyawan UA; Sartono TR
J Clin Lab Anal; 2021 Jun; 35(6):e23806. PubMed ID: 33945177
[TBL] [Abstract][Full Text] [Related]
17. Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis.
Neofytos D; Railkar R; Mullane KM; Fredricks DN; Granwehr B; Marr KA; Almyroudis NG; Kontoyiannis DP; Maertens J; Fox R; Douglas C; Iannone R; Kauh E; Shire N
PLoS One; 2015; 10(6):e0129022. PubMed ID: 26107507
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of DNA, (1-3)-beta-d-glucan, and galactomannan detection in serum and bronchoalveolar lavage of mice experimentally infected with Aspergillus terreus.
Ahmad S; Khan ZU; Theyyathel AM
Diagn Microbiol Infect Dis; 2007 Oct; 59(2):165-71. PubMed ID: 17574786
[TBL] [Abstract][Full Text] [Related]
19. Diverse clinical characteristics of Aspergillus growth in patients with cystic fibrosis.
Emiralioğlu N; Doğru D; Doğan Ö; Gülmez D; Akdağlı SA; Polat SE; Tuğcu G; Hızal MG; Yalçın E; Özçelik U; Şener B; Kiper N
Turk J Pediatr; 2020; 62(4):560-568. PubMed ID: 32779408
[TBL] [Abstract][Full Text] [Related]
20. Comparative accuracy of 1,3 beta-D glucan and galactomannan for diagnosis of invasive fungal infections in pediatric patients: a systematic review with meta-analysis.
Singh S; Singh M; Verma N; Sharma M; Pradhan P; Chauhan A; Jaiswal N; Chakrabarti A; Singh M
Med Mycol; 2021 Feb; 59(2):139-148. PubMed ID: 32448907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
